Insulin-like growth factors regulate neuronal differentiation and survival

Neurobiology of Disease

Volumn 4, Issue 3-4, 1997, Pages 201-214

  Feldman, Eva L ^a   Sullivan, Kelli A ^b   Kim, Bhumsoo ^a   Russell, James W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

APOPTOSIS; CELL SURVIVAL; GROWTH CONE; GROWTH REGULATION; MOTONEURON; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORY NERVE;

EID: 0030717725     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1997.0156     Document Type: Article

References (130)

1. Abedi H., Dawes K. E., Zachary I. Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J. Biol. Chem. 270:1995;11367-11376.
2. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinasein vitroin vivo. J. Biol. Chem. 270:1995;27489-27494.
3. Allsopp T. E., Wyatt S., Paterson H. F., Davies A. M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 73:1994;295-307.
4. Alnemri E. S., Livingston D. J., Nicholson D. W., Salvesen G., Thornberry N. A., Wong W. W., Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 87:1996;171.
5. Araujo D. M., Lapchak P. A., Collier B., Chabot J.-G., Quirion R. Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: Distribution and interaction with the hippocampal cholinergic system. Brain Res. 484:1989;130-138.
6. Backstrom M., Hall K., Sara V. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders. Acta Endocrinol. (Copenhagen). 107:1984;171-178.
7. Barinaga M. Cell suicide: By ICE, not fire. Science. 263:1994;754-756.
8. Baur A. M., Gamberger T. I., Weerda H. G., Gjuric M., Tamm E. R. Laminin promotes differentiation, adhesion and proliferation of cell cultures derived from human acoustic nerve schwannoma. Acta Oto-Laryngol. 115:1995;517-521.
9. Beck F., Samani N. J., Byrne S., Morgan K., Gebhard R., Brammar W. J. Histochemical localization of IGF-I and IGF-II mRNA in the rat between birth and adulthood. Development. 104:1988;29-39.
10. Bissonette R. P., Echeverri F., Mahboubi A., Green D. R. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359:1992;552-554.
11. Boise L. H., Gonzalez-Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nunez G., Thompson C. B. bcl-x,bcl-2. Cell. 74:1993;597-608.
12. Bondy C. A., Werner H., Roberts C. T. Jr., LeRoith D. Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: Comparison with IGF-II gene expression. Mol. Endocrinol. 4:1990;1386-1398.
13. Bondy C., Werner H., Roberts C. T. Jr., LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: Comparison with insulin-like growth factors I and II. Neuroscience. 46:1992;909-923.
14. FAK. J. Cell Biol. 119:1992;893-903.
15. Cheng H-L., Feldman E. L. Insulin-like growth factor-I (IGF-I) and IGF binding protein-5 in Schwann cell differentiation. J. Cell. Physiol. 171:1997;161-167.
16. Cheng H-L., Randolph A., Yee D., Delafontaine P., Tennekoon G., Feldman E. L. Characterization of insulin-like growth factor-I (IGF-I), IGF-I receptor and binding proteins in transected nerves and cultured Schwann cells. J. Neurochem. 66:1996;525-536.
17. Chinnaiyan A. M., Dixit V. M. The cell death machine. Curr. Biol. 6:1996;555-562.
18. L. J. Biol. Chem. 271:1996;4573-4576.
19. Chu Y.-W., Seftor E. A., Romer L. H., Hendrix M. J. C. Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am. J. Pathol. 148:1996;63-69.
20. Clemmons D. R. Structural and functional analysis of insulin-like growth factors. Br. Med. Bull. 45:1989;465-480.
21. Corcoran G. B., Fix L., Jones D. P., Moslen M. T., Nicotera P., Oberhammer F. A., Buttyan R. Contemporary issues in toxicology. Apoptosis: Molecular control point in toxicity. Toxicol. Appl. Pharmacol. 128:1994;169-181.
22. Cramer L. P., Mitchison T. J., Theriot J. A. Actin-dependent motile forces and cell motility. Curr. Biol. 6:1994;82-86.
23. Darmon A. J., Nicholson D. W., Bleackley R. C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 377:1995;446-448.
24. Datta K., Bellacosa A., Chan T. O., Tsichlis P. N. Akt is a direct target of the phosphatidylinositol 3-kinase - Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J. Biol. Chem. 271:1996;30835-30839.
25. Daughaday W. H., Rotwein P. Insulin-like growth factor I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10:1989;68-91.
26. De Meyts P., Wallach B., Christoffersen C. T., Urso B., Gronskov K., Latus L.-J., Yakushiji F., Ilondo M. M., Shymko R. M. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction. Horm. Res. 42:1994;152-169.
27. D'Mello S. R., Borodezt K., Soltoff S. P. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: Possible involvement of PI 3-kinase in IGF-1 signaling. J. Neurosci. 17:1997;1548-1560.
28. D'Mello S. R., Galli C., Ciotti T., Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA. 90:1993;10989-10993.
29. Doerr M. E., Jones J. I. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J. Biol. Chem. 271:1996;2443-2447.
30. Donovan S. M., Oh Y., Pham H., Rosenfeld R. G. Ontogeny of serum insulin-like growth factor binding proteins in the rat. Endocrinology. 125:1989;2621-2627.
31. Dore S., Kar S., Quirion R. Rediscovering an old friend, IGF-I: Potential use in the treatment of neurodegenerative diseases. Trends Neurosci. 20:1977;326-331.
32. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R., Greenberg M. E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-665.
33. Eck M. J., Dhe-Paganon S., Trub T., Nolte R. T., Shoelson S. E. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell. 85:1996;695-705.
34. Feldman E. L., Randolph A. E. Mannose 6-phosphate potentiates insulin-like growth factor II effects in cultured human neuroblastoma cells. Brain Res. 562:1991;111-116.
35. Fernyhough P., Mill J. F., Roberts J. L., Ishii D. N. Stabilization of tubulin mRNAs by insulin and insulin-like growth factor I during neurite formation. Mol. Brain Res. 6:1989;109-120.
36. Forsythe I. D., Lambert D. G., Nahorski S. R., Linsdell P. Elevation of cytosolic calcium by cholinoceptor agonists in SH-SY5Y human neuroblastoma cells: Estimation of the contribution of voltage-dependent currents. Br. J. Pharmacol. 107:1992;207-214.
37. Frampton R. J., Jonas H. A., MacMahon R. A., Larkins R. G. Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal rats. J. Dev. Physiol. 13:1990;125-133.
38. Gammeltoft S., Haselbacher G. K., Humbel R. E., Fehlmann M., Van Obberghen E. Two types of receptor for insulin-like growth factors in mammalian brain. EMBO J. 4:1985;3407-3412.
39. Garcia I., Martinou I., Tsujimoto Y., Martinou J-C. Prevention of programmed cell death of sympathetic neurons by thebcl. Science. 258:1992;302-304.
40. Giancotti F. G., Mainiero F. Integrin-mediated adhesion and signaling in tumorigenesis. Biochim. Biophys. Acta Rev. Cancer. 1198:1994;47-64.
41. Han V. K. M., Lund P. K., Lee D. C., D'Ercole A. J. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization, and tissue distribution. J. Clin. Endocrinol. Metab. 66:1988.
42. Hansson H. A., Dahlin L. B., Danielsen N., Fryklund L., Nachemson A. K., Polleryd P., Rozell B., Skottner A., Stemme S., Lundborg G. Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves. Acta Physiol. Scand. 126:1986;609-614.
43. Hartwig J. H., Bokoch G. M., Carpenter C. L., Janmey P. A., Taylor L. A., Toker A., Stossel T. P. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell. 82:1995;643-653.
44. Haselbacher G. K., Schwab M. E., Pasi A., Humbel R. E. Insulin-like growth factor II (IGF II) in human brain: Regional distribution of IGF II and of higher molecular mass forms. Proc. Natl. Acad. Sci. USA. 82:1985;2153-2157.
45. Hockenbery D., Nunez G., Milliman C., Schreiber R. D., Korsmeyer S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
46. Hynes R. O., Lander A. D. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell. 68:1992;303-322.
47. Irving J. A., Lala P. K. Functional role of cell surface integrins on human trophoblast cell migration: Regulation by TGF-β, IGF-II, and IGFBP-1. Exp. Cell Res. 217:1995;419-427.
48. Ishii D. N., Wang C., Li Y. Second messengers mediating gene expression essential to neurite formation directed by insulin and insulin-like growth factors. Adv. Exp. Med. Biol. 293:1991;361-378.
49. Jacobson M. D., Evan G. I. Breaking the ice. Structural and functional similarities have been discovered between two mammalian proteins, Bcl-2 and interleukin 1β-converting enzyme, and proteins encoded by nematode cell-death genes. Curr. Biol. 4:1994;337-340.
50. Jacobson M. D., Weil M., Raff M. C. Programmed cell death in animal development. Cell. 88:1997;347-354.
51. Jalonen T., Akerman K. E. O. Single transient potassium channels in human neuroblastoma cells induced to differentiate in vitro. Neurosci. Lett. 86:1988;99-104.
52. Kapeller R., Cantley L. C. Phosphatidylinositol 3-kinase. BioEssays. 16:1994;565-576.
53. 125125125. J. Comp. Neurol. 333:1993;375-397.
54. Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 53:1993;3976-3985.
55. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 385:1977;544-548.
56. 3. Mol. Cell. Endocrinol. 90:1992;147-153.
57. Kim B., Feldman E. L. Insulin-like growth factor-I signaling mediates membrane ruffling and neurite outgrowth in human neurons. Endocr. Soc. Abstr. P3-581:1997;582.
58. Kim B., Leventhal P. S., Feldman E. L. Insulin-like growth factor-I (IGF-I) induces localization of RAC and phosphatidylinositol 3-kinase (PI3-K) to membrane ruffles. Mol. Biol. Cell. 7:1996;392a.
59. Kim B., Leventhal P. S., Feldman E. L. IGF-I mediates growth cone motility and axonal extension. Neurology. 48:1997a;44.
60. Kim B., Leventhal P. S., Saltiel A. R., Feldman E. L. Insulin-like growth factor (IGF)-I-mediated neurite outgrowth in vitro requires MAP kinase activation. J. Biol. Chem. 1997b.
61. Korsmeyer S. J. Regulators of cell death. Trends Genet. 11:1995;101-105.
62. Kotani K., Hara K., Yoneawa K., Kasuga K. Phosphoinositide 3-kinase as an upstream regulator of the small GTP-binding protein Rac in the insulin signaling of membrane ruffling. Biochem. Biophys. Res. Commun. 208:1995;985-990.
63. LeRoith D., Werner H., Beitner-Johnson D., Roberts C. T. Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16:1995;143-163.
64. Lesniak M. A., Hill J. M., Kiess W., Rojeski M., Pert C. B., Roth J. Receptors for insulin-like growth factors I and II: Autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology. 123:1988;2089-2099.
65. Leventhal P. S., Feldman E. L. Tyrosine phosphorylation and enhanced expression of paxillin during neuronal differentiationin vitro. J. Biol. Chem. 271:1996;5957.
66. Leventhal P. S., Feldman E. L. Insulin-like growth factors as regulators of cell motility: Signaling mechanisms. Trends Endocrinol. Metab. 8:1997;1-6.
67. Leventhal P. S., Kim B., Feldman E. L. Insulin-like growth factor-I stimulates the tyrosine phosphorylation of focal adhesion kinase and paxillin in SH-SY5Y human neuroblastoma cells. J. Neurochem. 66:1996;S80.
68. Leventhal P. S., Shelden E. A., Kim B., Feldman E. L. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance. J. Biol. Chem. 272:1997;5214-5218.
69. MacDonald R. G. Mannose-6-phosphate enhances cross-linking efficiency between insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptors in membranes. Endocrinology. 128:1991;413-421.
70. Mah S. P., Zhong L. T., Liu Y., Roghani A., Edwards R. H., Bredesen D. E. The protooncogenebcl. J. Neurochem. 60:1993;1183-1186.
71. Martin D. M., Feldman E. L. Regulation of insulin-like growth factor-II expression and its role in autocrine growth of human neuroblastoma cells. J. Cell. Physiol. 155:1993;290-300.
72. Martin D. M., Carlson R. O., Feldman E. L. Regulation of IGF-II gene expression during neuroblastoma proliferation and differentiation. Soc. Neurosci. Abstr. 17:1991;448.6.
73. Martin D. M., Carlson R. O., Feldman E. L. Interferon-γ inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells. J. Neurosci. Res. 34:1993;489-501.
74. Martin D. M., Singleton J. R., Meghani M. A., Feldman E. L. IGF receptor function and regulation in autocrine human neuroblastoma cell growth. Regul. Peptides. 48:1993;225-232.
75. Martin D. M., Yee D., Carlson R. O., Feldman E. L. Gene expression of the insulin-like growth factors and their receptors in human neuroblastoma cells. Mol. Brain Res. 15:1992;241-246.
76. Martinou J-C., Dubois-Dauphin M., Staple J. K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
77. FAK. J. Biol. Chem. 269:1994;31807-31813.
78. Matthews C. C., Feldman E. L. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J. Cell. Physiol. 166:1996;323-331.
79. Matthews C. C., Odeh H., Feldman E. L. Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience. 79:1997;525-534.
80. Mattson M. E., Hammerling U., Mohall E., Hall K., Pahlman S. Mitogenically uncoupled insulin and IGF-I receptors of differentiated human neuroblastoma cells are functional and mediate ligand-induced signals. Growth Factors. 2:1990;251-265.
81. McMorris F. A., Dubois-Dalcq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J. Neurosci. Res. 21:1988;199-209.
82. Meghani M. A., Martin D. M., Singleton J. R., Feldman E. L. Effects of serum and insulin-like growth factors on human neuroblastoma cell growth. Regul. Peptides. 48:1993;217-224.
83. Merry D. E., Veis D. J., Hickey W. F., Korsmeyer S. J. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development. 120:1994;301-311.
84. Miller T. M., Tansey M. G., Johnson E. M. Jr., Creedon D. J. Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells. J. Biol. Chem. 272:1997;9847-9853.
85. Mozell R. L., McMorris F. A. Insulin-like growth factor-I stimulates regeneration of oligodendrocytesin vitro. Ann. N. Y. Acad. Sci. 540:1988;430-432.
86. Nishida E., Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18:1993;128-131.
87. Nishiyama T., Sasaki T., Takaishi K., Kato M., Yaku H., Araki K., Matsuura Y., Takai Y. racrhoO. Mol. Cell Biol. 14:1994;2447-2456.
88. Nobes C. D., Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with stress fibers, lamellipodia, and filopodia. Cell. 81:1995;53-62.
89. Okabe S., Hirokawa N. Actin dynamics in growth cones. J. Neurosci. 11:1991;1918-1929.
90. Pahlman S., Mamaeva S., Meyerson G., Mattsson M. E., Bjelfman C., Ortoft E., Hammerling U. Human neuroblastoma cells in culture: A model for neuronal cell differentiation and function. Acta Physiol. Scand. Suppl. 592:1990;25-37.
91. Pahlman S., Meyerson G., Lindgren E., Schalling M., Johansson I. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. USA. 88:1991;9994-9998.
92. Pelech S. L., Sanghera J. S. Mitogen-activated protein kinases: Versatile transducers for cell signaling. Trends Biochem. Sci. 17:1992;233-238.
93. Pell J. M., Saunders J. C., Gilmour R. S. Differential regulation of transcription initiation from insulin-like growth factor-I (IGF-I) leader exons and of tissue IGF-I expression in response to changed growth hormone and nutritional status in sheep. Endocrinology. 132:1993;1797-1807.
94. Pittman R. N., Wang S., DiBenedetto A. J., Mills J. C. A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci. 13:1993;3669-3680.
95. Raff M. C., Barres B. A., Burne J. F., Coles H. S., Ishizaki Y., Jacobson M. D. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science. 262:1994;695-700.
96. Recio-Pinto E., Ishii D. N. Effects of insulin, insulin-like growth factor-II and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Brain Res. 302:1984;323-334.
97. Recio-Pinto E., Ishii D. N. Insulin and insulinlike growth factor receptors regulating neurite formation in cultured human neuroblastoma cells. J. Neurosci. Res. 19:1988;312-320.
98. Reed J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-6.
99. Reed J. C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
100. Resnicoff M., Sell C., Rubini M., Coppola D., Ambrose D., Baserga R., Rubin R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res. 54:1994a;2218-2222.
101. Resnicoff M., Coppola D., Sell C., Rubin R., Ferrone S., Baserga R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54:1994b;4848-4850.
102. Reuveny E., Narahashi T. Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells. Brain Res. 603:1993;64-73.
103. Ridley A. J. Membrane ruffling and signal transduction. BioEssays. 16:1994;321-327.
104. Ridley A. J., Paterson H. F., Johnston C. L., Diekmann D., Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 70:1992;401-410.
105. Roth K. A., Motoyama N., Loh D. Y. Apoptosis ofbcl-x. J. Neurosci. 16:1996;1753-1758.
106. Rotwein P., Burgess S. K., Milbrandt J. D., Krause J. E. Differential expression of insulin-like growth factor genes in rat central nervous system. Proc. Natl. Acad. Sci. USA. 85:1988;265-269.
107. Sanes J. R. Extracellular matrix molecules that influence neural development. Annu. Rev. Neurosci. 12:1989;491-516.
108. Sano M., Iwanaga M. Requirement for specific protein kinase activities during the rapid redistribution of F-actin that precedes the outgrowth of neurites in PC12D cells. Cell Struct. Function. 17:1992;341-350.
109. Sara V. R., Hall K. Insulin-like growth factors and their binding proteins. Physiol. Rev. 70:1990;591-614.
110. Sastry S. K., Horwitz A. F. Integrin cytoplasmic domains: Mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signalling. Curr. Opin. Cell Biol. 5:1993;819-831.
111. Schlegel J., Peters I., Orrenius S., Miller D. K., Thornberry N. A., Yamin T-T., Nicholson D. W. CPP32/apopain is a key interleukin 1β converting enzyme-like protease involved in fas-mediated apoptosis. J. Biol. Chem. 271:1996;1841-1844.
112. Shapiro D. N., Jones B. G., Shapiro L. H., Dias P., Houghton P. J. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest. 94:1994;1235-1242.
113. Singleton J. R., Dixit V. M., Feldman E. L. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271:1996a;31791-31794.
114. Singleton J. R., Randolph A. E., Feldman E. L. Insulin-like growth factor I receptor prevents apotosis and enhances neuroblastoma tumorigenesis. Cancer Res. 56:1996b;4522-4529.
115. Sjoberg J., Kanje M. Insulin-like growth factor (IGF-I) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res. 485:1989;102-108.
116. Sklar M. M., Kies W., Thomas C. L., Nissley S. P. Developmental expression of the tissue insulin-like growth factor II/mannose 6-phosphate receptor in the rat. J. Biol. Chem. 264:1989;16733-16738.
117. Sklar M. M., Thomas C. L., Municchi G., Roberts C. T. Jr., LeRoith D., Kiess W., Nissley P. Developmental expression of rat insulin-like growth factor-II/mannose 6-phosphate receptor messenger ribonucleic acid. Endocrinology. 130:1992;3484-3491.
118. Sobue K. Actin-based cytoskeleton in growth cone activity. Neurosci. Res. 18:1993;91-102.
119. Steele-Perkins G., Turner J., Edman J. C., Hari J., Pierce S. B., Stover C., Rutter W. J., Roth R. A. Expression and characterization of a functional human insulin-like growth factor I receptor. J. Biol. Chem. 263:1988;11486-11492.
120. Stewart C. E. H., Rotwein P. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76:1996;1005-1026.
121. Stossel T. P. On the crawling of animal cells. Science. 260:1993;1086-1094.
122. Sullivan K. A., Kim B., Buzdon M., Feldman E. L. Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells. Brain Res. 744:1997;199-206.
123. Sumantran V. N., Feldman E. L. Insulin-like growth factor I regulates c-myc. Endocrinology. 132:1993;2017-2023.
124. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zheng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M. Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
125. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
126. Trojan J., Blossey B. K., Johnson T. R., Rudin S. D., Tykocinski M., Ilan J. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA. 89:1992;4874-4878.
127. Van Evercooren A. B., Olichon-Berthe C. Expression of IGF-I and insulin receptor genes in the rat central nervous system: A developmental, regional, and cellular analysis. J. Neurosci. Res. 28:1991;244-253.
128. White M., Kahn C. R. The insulin signaling system. J. Biol. Chem. 269:1994;1-4.
129. Wyllie A. H. The genetic regulation of apoptosis. Curr. Opin. Genet. Dev. 5:1995;97-104.
130. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T-I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.